Nexus Surgical And Medicare Ltd

Nexus Surgical And Medicare Ltd has announced the closure of its trading window for all designated persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.

The Board of Directors of 538874, at their meeting held on May 28, 2026, has appointed M/s. VMRS & Co., Chartered Accountants, Mumbai (Firm Registration No. 122750W), as the Internal Auditors of the Company for the Financial Year 2026-27. This appointment is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. VMRS & Co., established in 2002, is a dynamic firm with offices in Mumbai and New Delhi, serving a diverse clientele including corporate, banking, and government organizations.

Nexus Surgical and Medicare Limited's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026. The company reported a net loss of ₹367.21 lakhs for the financial year 2026, with total income reaching ₹547.19 lakhs. Additionally, the Board appointed M/s. VMRS & Co., Chartered Accountants, as the Internal Auditors for the Financial Year 2026-27. The financial results were prepared in accordance with Indian Accounting Standards and reviewed by the Audit Committee.

Nexus Surgical and Medicare Limited's Board of Directors met on May 28, 2026, approving the audited financial results for the quarter and year ended March 31, 2026. The results, along with the Auditor's Report with an unmodified opinion, were submitted. Additionally, M/s. VMRS & Co., Chartered Accountants, Mumbai, were appointed as the Internal Auditors for the Financial Year 2026-27. The meeting commenced at 03:30 p.m. and concluded at 05:30 p.m. after transacting these key businesses.

Nexus Surgical And Medicare Ltd has announced a Board of Directors meeting scheduled for May 28, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The meeting will take place at the company's registered office. The trading window for designated persons will be closed until May 30, 2026.

Nexus Surgical And Medicare Ltd responded to a clarification sought by the Exchange regarding the price movement of the company's stock. The company stated that the price movement is purely due to market conditions and is market-driven. They confirmed compliance with SEBI (LODR) Regulations, 2015, and stated that there is no undisclosed price-sensitive information or impending corporate action to be disclosed at this time.

Nexus Surgical And Medicare Ltd has announced the closure of the trading window for all designated persons for the quarter ended 31st March, 2026. The closure is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from 1st April, 2026 till the expiry of 48 hours after the declaration of the Audited Financial Results of the Company for the year ended 31st March, 2026.

The Board of Directors of Nexus Surgical and Medicare Limited approved the unaudited quarterly financial results for the quarter and nine months ended December 31, 2025 during their meeting on February 14, 2026. The results were reviewed and recommended by the audit committee and approved by the Board. The Statutory Auditors carried out a Limited Review of the aforesaid results. The company is primarily engaged in the trading business and did not receive any shareholder/investor complaints during the quarter.

The Board of Directors of Nexus Surgical and Medicare Ltd. approved the unaudited quarterly financial results for the quarter and nine months ended 31st December, 2025 during their meeting on 14th February, 2026. The results were reviewed and recommended by the audit committee and approved by the Board. The Statutory Auditors have carried out a Limited Review of the aforesaid results. The company is primarily engaged in the trading business and has not received any shareholder/investor complaints during the quarter.

Nexus Surgical And Medicare Ltd has announced a Board of Directors meeting on February 14, 2026, to consider and approve the unaudited financial results for the quarter ended 31st December 2025. The meeting will take place at the company's registered office. The trading window for all designated persons will remain closed until February 16, 2026.